PATENT CLAIM ANALYSIS

Application Number: 15764988
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The present disclosure provides tetrahydro-1H-pyrido[3,4-b]indole compounds or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, stereoisomer, tautomer, rotamer, N-oxide and/or substituted derivative or, optionally in a pharmaceutical composition, for the modulation of disorders mediated by estrogen, or other disorders as more fully described herein.

Claim (Index 1):
A compound of Formula I: wherein: X is \u2014CH 2 \u2014 or \u2014O\u2014; Y is R 1 , R 2 , R 3 , and R 4  are each independently selected from hydrogen or halo; R 5  is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 1 -C 4 (C 3 -C 6 cycloalkyl) or C 1 -C 6 heteroalkyl; R 6  is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 4 (C 3 -C 6 cycloalkyl); R 7  and R 8  are each independently selected from hydrogen or C 1 -C 6 alkyl; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 81.0
- Percentile: 90.0
- Lexical Diversity: 1.28889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15893295', '15374966', '13717326', '15531245', '12710693']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7854704877579672
- 35 USC 102 Novelty (BERT): 0.5279495827570325
- Combined Prediction Score: 0.7597183972578738
- Mean Citation Score: 294.242924
- Max Citation Score: 338.2961
- Similarity Product: 233.0455270989776

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test